Skip to main content

Table 7 Similar studies in detail

From: Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence

Authors Year N Age FU % bounce ≥ +2 ng/ml Delay Amplitude Nadir duration Bounce cause BF & bounce Alternative definitions
Crook et al. [14] 2007 275 64 (45-80) 44 40 15% 15.2 (3-29) 0.76 (0.21-11.79) -- 6.8 (3-50) Age Delay --
Mitchell et al. [21] 2008 205 62 (43-75) 45 37 7.5% 14.9 (1.7-40.6) 0.91 (0.2-5.8) 1.4 (0.1-6.9) 11.3 (2.3-32.5) Age V PSA (using Phoenix def) --
Zwahlen et al. [34] 2010 194 62 (47-75) 60 50 11.3% 14 (0-70) 0.5 (0.2-8.3) 0.1 (0-3.5) 12 (2-43) Age Delay ≥ 0.4 ng/ml: 34
              ≥ 15%: 11
              ≥ 35%: 9
Mazeron (this study) 2012 198 67 (49-80) 64 36 12.7% 17 (3.6-50.2) 0.6 (0.2-5.1) 1.4 (0.02-6.6) 13.6 (4-44.9 Age 6 week PSA assessment delay ≥ 0.1 ng/ml: 49
              ≥ 15%: 52
              ≥ 35%: 36